CVie-216

N/A

Report date: 2024/03/08 17:56:32
NME

Base Information

Drug NameCVie-216
Drug Alias NameCVie-216
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSarcoplasmic/endoplasmic reticulum calcium ATPase 2 activators
TargetsSarcoplasmic/endoplasmic reticulum calcium ATPase 2
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWindtree Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesWindtree Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A